Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
11.26
-0.69 (-5.82%)
Sep 23, 2026, 4:00 PM EDT - Market closed
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of $3.85 billion as of September 23, 2026. Its market cap has increased by 15.07% in one year.
Market Cap
3.85B
Enterprise Value
4.18B
1-Year Change
15.07%
Ranking
Category
Stock Price
$11.26
ChartMarket Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from $115.28M to $3.85B, an increase of 3,237.79%. That is a compound annual growth rate of 48.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 3.85B | 52.05% |
| Dec 31, 2025 | 2.53B | -50.36% |
| Dec 31, 2024 | 5.10B | 129.18% |
| Dec 29, 2023 | 2.22B | 42.30% |
| Dec 30, 2022 | 1.56B | -2.70% |
| Dec 31, 2021 | 1.61B | 96.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Edgewise Therapeutics | 4.33B |
| ACADIA Pharmaceuticals | 4.32B |
| Parabilis Medicines | 4.10B |
| Tango Therapeutics | 4.07B |
| AbCellera Biologics | 3.94B |
| Celcuity | 3.90B |
| Relay Therapeutics | 3.81B |
| IDEAYA Biosciences | 3.59B |